Assess the Safety, Tolerability, PK and Anti-tumor Efficacy of DZD2269 in Patients With MCRPC
Clinical trial NCT04634344 · TERMINATED
Trial details
- NCT number
- NCT04634344
- Sponsor
- Dizal Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-12
- Primary completion
- 2022-05-05
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.